Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2014
06/04/2014CN103830193A Indacaterol tablets and preparation method thereof
06/04/2014CN103830192A Tenofovir disoproxil fumarate tablets allowing direct powder compression and preparation method thereof
06/04/2014CN103830189A Recombinant insulin glargine preparation and preparation method thereof
06/04/2014CN103830184A Solid dispersion system of febuxostat and preparation method of solid dispersion system, and pharmaceutical applications
06/04/2014CN103830183A Ampicillin soluble powder and preparation method thereof
06/04/2014CN103830181A Docetaxel freeze-dried lipidosome and preparation method thereof
06/04/2014CN103830179A Crotamiton-containing external preparation and preparation process thereof
06/04/2014CN103830178A Alliin micro-emulsion as well as preparation method and application for same
06/04/2014CN103830177A Gemcitabine hydrochloride injection and preparation method thereof
06/04/2014CN103830176A Baicalin emulsion and preparation method thereof
06/04/2014CN103830171A Ketorolac tromethamine injection and preparation method thereof
06/04/2014CN103830170A Ivermectin in-vivo gel injection and preparation method thereof
06/04/2014CN103830167A Preparation method of slow-release ivermectin injection
06/04/2014CN103830165A Flukanide transdermal solution used for treating parasitic diseases of cattle and sheep, and preparation method thereof
06/04/2014CN103830163A Production of adapalene gels
06/04/2014CN103830162A Preparation method of doxycycline gel
06/04/2014CN103829241A Method for controlling protein peptic solidification
06/04/2014CN103828840A Antibacterial powder and preparation method thereof
06/04/2014CN103191153B Muscular amino acid and nucleoside extract and pharmaceutical composition thereof
06/04/2014CN103169946B Application of Safenour cyclopeptide in oral insulin medicine for treating diabetes
06/04/2014CN103006607B Lansoprazole enteric-coated tablet and method for preparing same
06/04/2014CN102961360B Oxymatrine hepatic targeting nano drug delivery system and preparation method thereof
06/04/2014CN102952385B Modified halloysite nanotube / biodegradable polyester composite material and preparation method thereof
06/04/2014CN102908315B Chitosan (CS) nanoparticle delivery system of small molecular interfering ribonucleic acid and preparation method thereof
06/04/2014CN102908312B Liquid combination for resisting hepatitis B viruses
06/04/2014CN102876681B Nucleic acid aptamer for targeted medicament carrier
06/04/2014CN102793699B Medicinal composition containing dabigatran etexilate
06/04/2014CN102784390B Method for preparing thermal-stability vaccine
06/04/2014CN102690857B Method for preparing medium-low molecular weight dextran by using biological method
06/04/2014CN102641252B Terbinafine hydrochloride solid dispersoid and tablet thereof
06/04/2014CN102617764B Method for preparing monodisperse submicron polystyrene spheres by intermediate-and low-temperature solvent thermal process
06/04/2014CN102614106B Drug controlled release nanofibers and preparation method thereof
06/04/2014CN102596206B Pharmaceutical composition for oral administration
06/04/2014CN102585016B Immune fusion protein capable of inhibiting T and B lymphocyte functions and preparation method and application thereof
06/04/2014CN102453089B Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate
06/04/2014CN102311493B Peptide inhibiting telomerase activity, its preparation method and application
06/04/2014CN102311454B Compound lipid containing porphyrin ring functional groups, preparation method and application thereof
06/04/2014CN102210653B Burdock aglycone microemulsion
06/04/2014CN102178646B Stable Tegafur injection and preparation method thereof
06/04/2014CN102159251B Method for the preparation of a controlled release system
06/04/2014CN102085198B Transdermal delivery systems
06/04/2014CN102000042B Controlled release preparations
06/04/2014CN101708338B Prodrug containing sterides structures and high dispersion preparation thereof
06/04/2014CN101613409B PDGFR-alpha antibody
06/04/2014CN101601670B Compound niclosamide parasite-expelling tablet used for pet and preparation method thereof
06/03/2014US8742091 Method of promoting nucleic acid transfer
06/03/2014US8742090 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
06/03/2014US8742013 Synthesis of lipoamide-grafted high molecular compound and method therefor
06/03/2014US8741970 Composition and method for the enhancement of the efficacy of drugs
06/03/2014US8741969 Anti-adhesion membrane
06/03/2014US8741941 Antifungal medicinal compositions
06/03/2014US8741935 Nicotine delivery product and method for producing it
06/03/2014US8741869 Oligodeoxynucleotide and its use to induce an immune response
06/03/2014US8741834 Dipeptoid prodrugs and the use thereof
06/03/2014US8741351 Microspheres for active embolization
06/03/2014US8741347 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
06/03/2014US8741346 Method for the preparation of molecular complexes
06/03/2014US8741339 Active targeting polymer micelle encapsulating drug, and pharmaceutical composition
06/03/2014US8741314 Multivalent meningococcal polysaccharide-protein conjugate vaccine
06/03/2014US8741303 Immunogenic LHRH compositions and methods relating thereto
06/03/2014US8741270 Bonding tissues and cross-linking proteins with naphthalimide compounds
06/03/2014CA2799437C Method of producing hydroxyalkyl starch derivatives
06/03/2014CA2671081C Stabilized adhesive preparation containing donepezil
06/03/2014CA2649538C Buffering agents for biopharmaceutical formulations
06/03/2014CA2648854C Fluid container and airless fluid dispensing system
06/03/2014CA2633356C Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
06/03/2014CA2595617C Formulations for injection of catecholic butanes, including ndga compounds, into animals
06/03/2014CA2578225C Testosterone gels comprising propylene glycol as penetration enhancer
06/03/2014CA2562767C Implantable pump for protein delivery for obesity control by drug infusion into the brain
06/03/2014CA2434490C Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
06/03/2014CA2432523C Compositions of stable t3 and methods of use thereof
06/03/2014CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
05/2014
05/30/2014WO2014082065A1 Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
05/30/2014WO2014081941A1 Methods and compositions for locally increasing body fat
05/30/2014WO2014081674A1 Topical dapsone and dapsone/adapalene compositions and methods for use thereof
05/30/2014WO2014081581A2 Highly loaded amorphous efavirenz composition and process for preparing the same
05/30/2014WO2014081340A1 Inhalation composition in the form of an aerosol for the treatment of bronchial asthma and chronic obstructive pulmonary disease
05/30/2014WO2014081338A1 Medicinal agent in the form of an orodispersible tablet and method for producing same
05/30/2014WO2014081303A1 Chemically cleavable group
05/30/2014WO2014081301A1 Bio-orthogonal drug activation
05/30/2014WO2014081300A1 Channel protein activatable liposomes
05/30/2014WO2014081299A1 Activatable liposomes
05/30/2014WO2014080999A1 Noble metal nanoparticle aggregate reagent, and detection and heat generation method using said reagent
05/30/2014WO2014080997A1 Anti-midkine aptamer and applications thereof
05/30/2014WO2014080784A1 Aqueous olanzapine pharmaceutical preparation of having longterm stability
05/30/2014WO2014080730A1 Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
05/30/2014WO2014080285A2 Pharmaceutical compositions having improved storage stability
05/30/2014WO2014080251A1 Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
05/30/2014WO2014079914A1 Cd44v6-derived pegylated peptides
05/30/2014WO2014079890A1 Titanate nanostructure for regenerating and engineering tissue
05/30/2014WO2014079384A1 Trophic hormone fusion protein, preparation method and application thereof
05/30/2014WO2014079377A1 Antitumor prodrugs with function of p-glycoprotein inhibition
05/30/2014WO2014079158A1 Active-targeting, small interference ribonucleic acid delivery vector and preparation method thereof
05/30/2014WO2014079020A1 Pharmaceutical composition used for reducing damage caused by free radicals
05/30/2014WO2014078942A1 Compositions, uses and methods for treating or preventing dental caries
05/30/2014WO2014078912A1 Coating composition
05/30/2014WO2014057432A9 Multicomponent lipid nanoparticles and processes for the preparation thereof
05/30/2014WO2014054005A3 Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-β-cyclodextrin for intravenous use in cerebral pathological conditions
05/30/2014WO2013037479A8 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
05/29/2014US20140148515 System and method for alleviating the appearance of scars and/or scar tissue
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 1712